Experimental study of the detrimental effect of dopamine/glucagon combination in d,I-propranolol intoxication

Human and Experimental Toxicology

Volumn 15, Issue 5, 1996, Pages 411-421

  Toet, A E ^a,b   Werner, J ^a   Vleeming, W ^a   Te Biesebeek, J D ^a   Meulenbelt, J ^b,c   De Wildt, D J ^a,c  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cardiovascular function; Dopamine; Glucagon; Propranolol intoxication; Respiratory function; Survival

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOPAMINE; GLUCAGON; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL CARBON DIOXIDE TENSION; ARTERIAL OXYGEN TENSION; ARTICLE; ARTIFICIAL VENTILATION; BLOOD PH; CARDIOVASCULAR FUNCTION; CAUSE OF DEATH; CONTROLLED STUDY; DRUG OVERDOSE; FEMALE; HEART LEFT VENTRICLE PRESSURE; HEART RATE; HEMODYNAMICS; INTOXICATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; RESPIRATORY ARREST; RESPIRATORY FAILURE; SURVIVAL TIME;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOOD GAS ANALYSIS; BLOOD PRESSURE; CALCIUM; DISEASE MODELS, ANIMAL; DOPAMINE; DRUG INTERACTIONS; GLUCAGON; HEART RATE; LACTATES; MALE; OVERDOSE; PARTIAL PRESSURE; PROPRANOLOL; RABBITS; RANDOM ALLOCATION; RATS; RATS, WISTAR; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; SPECIES SPECIFICITY; SPECIFIC PATHOGEN-FREE ORGANISMS; STEREOISOMERISM; VENTRICULAR FUNCTION, LEFT;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0029944032     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/096032719601500509     Document Type: Article

References (59)

1. Riker CD, Wright RK, Matusiak W, Tuscan BE de. Massive metoprolol ingestion associated with a fatality - a case report. Journal of Forensic Sciences 1987; 32: 1447-1452.
2. Rohrig TP, Rundle DA. Fatality resulting from metoprolol overdose. Journal of Analytical Toxicology 1987; 11: 231-232.
3. Admundson DE, Brodine SK. A fatal case of PRO poisoning. Drug Intelligence and Clinical Pharmacy 1988; 22: 781-782.
4. Perrot D et al. A case of sotalol poisoning with fatal outcome. Clinical Toxicology 1988; 26: 389-396.
5. Suarez RV, Greenwald MS, Geraghty E. Intentional overdosage with propranolol. American Journal of Forensic Medicine and Pathology 1988; 9: 45-47.
6. Frishman W, Silverman R. Clinical pharmacology of the new beta-adrenergic locking drugs. Part 8. Self-poisoning with beta-adrenoceptor blocking agents: recognition and management. American Heart Journal 1979; 98: 798-811.
7. Eibs HG, Oberdisse U, Brambach U. Vergiftigungen mit beta-receptoren blockern bei kindern und jugendlichen. Monatsschrift Kinderheilkunde 1982; 130: 292-295.
8. Weinstein RS, Cole S, Knaster HB, Dahlbert T. Beta-blocker overdose with propranolol and with atenolol. Annals of Emergency Medicine 1985; 14: 161-163.
9. Taboulet P, Cariou A, Berdeaux A, Bismuth C. Pathophysiology and management of self-poisoning with beta-blockers. Clinical Toxicology 1993; 31: 531-551.
10. Langemeijer JJM, Wildt DJ de, Groot G de, Sangster B. Intoxication with beta-sympaticolytics (review). Netherlands Journal of Medicine 1992; 40: 308-315.
11. Health A. β-adrenoceptor blocker toxicity. Clinical features and therapy. American Journal of Emergency Medicine 1984; 2: 518-525.
12. Critchely JAJH, Ungar A. The management of acute poisoning due to β-adrenoceptor antagonists. Medical Toxicology 1989; 4: 32-45.
13. Eibs HG, Oberdisse U, Brambach U. Intoxikation mit beta-rezeptorenbockern. Deutsche Medizinische Wochenschrift 1982; 107: 1139-1143.
14. Schwela H et al. Intoxikationen mit β-rezeptorenblockern. Gesundheitwesen 1983; 38: 314-320.
15. Oltmans G et al. Acute β-blocker intoxikationen. Zeitschrift für die Gesamte Innere Medizin 1985; 40: 546-551.
16. Jackson CD, Fishbein L. A toxicological review of beta-adrenergic blockers. Fundamental and Applied Toxocology 1986; 6: 395-422.
17. Benowitz NL. Beta-adrenoceptro blocker poisoning. In: Clinical Management of Poisoning and Drug Overdose, Edited by LM Haddad, JF Winchester 1990, 2nd edition: 1315-1325.
18. Strubelt O. Evaluation of antidotes against the acute cardiovascular toxicity of propranolol. Toxicology, 1984; 31: 261-270.
19. Kahn MI, Miller MT. Beta-blocker toxicity - the role of glucagon. Report of 2 cases. South African Medical Journal 1985; 67: 1062-1063.
20. Critchely JAJH, Ungar A. The management of acute poisoning due to β-adrenoceptor anatagonists. Medical Toxicology 1989; 4: 32-45.
21. Ehgartner GR, Zelinka MA. Hemodynamic instability following intentional nadolol overdose. Archives of Internal Medicine 1988; 148: 801-802.
22. Kenyon JC. Successful resuscitation using external cardiac pacing in beta adrenergic antagonist-induced bradyasystolic arrest. Annals of Emergency Medicine 1988; 17: 711-713.
23. Lewis M et al. Survival following a massive overdose of adrenergic blocker agents (acebutolol and labetalol]. European Heart Journal 1983; 4: 328-332.
24. Horn PT, Murphy MB. Therapeutic applications of drugs acting on peripheral dopamine receptors. Journal of Clinical Pharmacology 1990; 30: 674-679.
25. Lipman J, Plit M. A guide to the rational use of dopamine, dobutamine and isoprenaline in patients who need inotropic support. Suidafrikaanse Mediese Tydskrif 1984; 65: 506-509.
26. Beregovich J, Bianchi C, Rubler S. Dose-related hemodynamic and renal effects of dopamine in congestive heart failure. American Heart Journal 1974; 87: 550-557.
27. Colucci WS, Wright RF, Braunwald E. New positive inotropic agents in the treatment of congestive heart failure. New England Journal of Medicine 1986; 314: 349-358.
28. Hosgood G. Pharmacologic features and physiologic effects of dopamine. Journal of the American Veterinary Medical Association 1990; 197: 1209-1211.
29. Pollack CV. Utility of glucagon in the emergency department. Journal of Emergency Medicine 1993; 11: 195-205.
30. Chernow B et al. Glucagon's chronotropic action is calcium dependent. Journal of Pharmacology and Experimental Therapeutics 1987; 241: 833-837.
31. Bygrave FL, Benedetti A. Calcium: Its modulation in liver by cross-talk between the action of glucagon and calcium-mobilizing agonists. Biochemical Journal 1993; 296: 1-14.
32. Kosinski E, Malindzak G. Glucagon and isoproterenol in reversing propranolol toxicity. Archives of Internal Medicine 1973; 132: 840-843.
33. O'Mahoney D, O'Leary P, Malloy MG. Severe oxoprenolol poisoning: The importance of glucagon infusion. Human and Experimental Toxicology 1990; 9: 101-103.
34. Adlerfliegel F, Leeman M, Demaeyer PH, Kahn RJ. Sotatol poisoning associated with asystole. Intensive Care Med 1993; 19: 57-58.
35. Buiumsohn A et al. Seizures and intraventricular conduction defect in propranolol poisoning. Annals of Internal Medicine 1979; 91: 860-862.
36. Illingworth RN. Glucagon for beta-blocker poisoning. Practitioner 1979; 223: 683.
37. Peterson CD, Leader JS, Sterner S. Glucagon therapy for β-blocker overdose. Drug Intelligence and Clinical Pharmacy 1984; 18: 394-397.
38. Sangster B, Wildt DJ de, Dijk A van. A case of acebutolol intoxication. Journal of Toxicology 1984; 20: 69-77.
39. Smith RC, Wilkinson J, Hull RL. Glucagon for propranolol overdose. JAMA 1985; 254: 2412.
40. Langemeijer JJM. Beta-blocker intoxication, an experimental study. Thesis, Utrecht, The Netherlands, 1988.
41. Love JN, Leasure JA, Mundt DJ, Janz TG. A comparison of amrinone and glucagon therapy for cardiovascular depression associated with propranolol toxicity in a canine model. Clinical Toxicology 1992; 30: 339-412.
42. Schneider JR et al. Glucagon effect on postichemic recovery of intestinal; energy metabolism. Journal of Surgical Research 1994; 56: 123-129.
43. Clark ET, Gewertz BL. Glucagon potentiates intestinal reperfusion injury. Journal of Vascular Surgery 1990; 11: 270-277.
44. Langemeijer JJM, Wildt DJ de, Groot G de, Sangster B. Respiratory arrest as main determinant of toxicity due to overdose with different beta-blockers in rat. Toxicology and Applied Pharmacology 1987; 89: 399-407.
45. Than N et al. Effects of acidosis and hypoxia on the response of isolated ferret cardiac muscle to inotropic agents. Cardiovascular Research 1994; 28: 1209-1217.
46. Farah AE. Glucagon and the circulation. Pharmacological Reviews 1983; 35: 181-217.
47. Manchester JH et al. Effects of glucagon on myocardial oxygen consumption and coronary blood flow in man and dog. Circulation 1970; 41: 579-588.
48. Hall-Boyer K, Zaloga P, Chernow B. Glucagon: Hormone or therapeutic agent? Critical Care Medicine 1984; 12: 584-589.
49. Hayes MA et al. Elevation of systemic oxygen delivery in the treatment of critically ill patients. New England Journal of Medicine 1994; 330: 1717-1722.
50. Langemeijer JJM, Wildt DJ de, Groot G de, Sangster B. Centrally induced respiratory arrest: a main cause of death in beta-adrenoceptor antagonist intoxication. Human Toxicology 1986; 5: 65.
51. Schenck H von. Glucagon-Biochemistry, Physiology and Pathophysiology. A review article. Acta Medica Scandinavian 1981; 209: 145-148.
52. Sorensen EV, Nielsen-Kudsk F. Myocardial pharmacodynamics of dopamine, dobutamine, amrinone and isoprenaline compared in the isolated rabbit heart. European Journal of Pharmacology 1986; 124: 51-57.
53. Mutnick AH, Szymusiak-Mutnick B, Drea EJ. Dopamine versus dobutamine: are all the facts there? Pharmacotherapy 1990; 10: 224-229.
54. Click G, Parmley WW, Wechsler AS, Sonnenblick EH. Glucagon. Its enhancement of cardiac performance in the cat and in the dog and persistence of its inotropic action despite beta-receptor blockade with propranolol. Circulation Research 1968; 22: 789-799.
55. Bakker J. Tissue oxygenation in septic shock: A persisting challenge. Thesis 1994.
56. Henning RJ, Weil MH, Weiner F. Blood lactate as a prognostic indicator of survival in patients with acute myocardial infarction. Circulatory Shock 1982; 9: 989-1001.
57. Suguihara C, Hehre D, Bancalari E. Effects of dopamine on hypoxic ventilatory response of sedated piglets with intact and denervated carotid bodies. Journal of Applied Phsyiology 1994; 77: 285-289.
58. Ponte J, Sadler CL. Interactions between hypoxia, acetylcholine and dopamine in the carotid body of rabbit and cat. Journal of Physiology 1989; 410: 395-410.
59. Böhmer G et al. Dopaminergic control of respiration as shown by effects of 4-aminopyridine. European Journal of Pharmacology 1986; 120: 335-344.